A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer
- 1 April 2000
- journal article
- research article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 53 (4), 367-375
- https://doi.org/10.1016/s0895-4356(99)00179-1
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- BRCA1 and BRCA2 gene mutations and risk of breast cancer:American Journal of Preventive Medicine, 1999
- Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysisPublished by Wolters Kluwer Health ,1998
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- Hormone replacement therapy as a risk factor for epithelial ovarian cancer: Results of a case-control studyPublished by Wolters Kluwer Health ,1998
- Characteristics Relating to Ovarian Cancer Risk: Collaborative Analysis of Seven U.S. Case-Control Studies. Epithelial Ovarian Cancer in Black WomenJNCI Journal of the National Cancer Institute, 1993
- Characteristics Relating to Ovarian Cancer Risk: Collaborative Analysis of 12 US Case -Control StudiesAmerican Journal of Epidemiology, 1992
- NONCONTRACEPTIVE ESTROGEN USE AND EPITHELIAL OVARIAN CANCERAmerican Journal of Epidemiology, 1989
- Risk factors for ovarian cancer: a case-control studyBritish Journal of Cancer, 1989
- MENOPAUSE AND OVARIAN CANCERAmerican Journal of Epidemiology, 1988
- Ovarian cancer.Incidence and case-control studyCancer, 1979